PMID- 35400474 OWN - NLM STAT- MEDLINE DCOM- 20220412 LR - 20220525 IS - 1873-7145 (Electronic) IS - 0963-9969 (Linking) VI - 155 DP - 2022 May TI - Screening and identification of high bioavailable oligopeptides from rapeseed napin (Brassica napus) protein-derived hydrolysates via Caco-2/HepG2 co-culture model. PG - 111101 LID - S0963-9969(22)00158-2 [pii] LID - 10.1016/j.foodres.2022.111101 [doi] AB - Rapeseed napin (Brassica napus) protein-derived hydrolysates (RNPHs, 1-4) are mixtures of peptides, prior to reaching liver tissue and playing their antidiabetic role, at least being absorbed and metabolized by the intestinal barrier. The study aims at screening and identifying high bioavailable rapessed napin-derived oligopeptides via simulated gastrointestinal digestion and absorption. Specifically, RNPHs were obtained using a novel ultrasound-assisted digestive device. The potential capacity of treating type 2 diabetes mellitus (T2DM) was evaluated preliminarily via enhancing glucose transporter 4 (GLUT4) expression and translocation. Also, absorbable rapeseed napin-derived oligopeptides were screened and identified in a Caco-2/HepG2 co-culture model using liquid chromatography coupled with electrospray ionisation and quadrupole time of flight tandem mass spectrometry (LC-ESI-QTOF-MS). The results involved mainly two aspects. First, absorbable oligopeptides from RNPH-1 (Molecular weight, Mw